Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/22/2001 | WO2001035995A3 Tr3-specific binding agents and methods for their use |
11/22/2001 | WO2001034805A3 Human vanilloid receptor gene |
11/22/2001 | WO2001032845A3 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith |
11/22/2001 | WO2001027269A3 Vip54 protein and related materials |
11/22/2001 | WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
11/22/2001 | WO2001027146A3 Chemokine receptor |
11/22/2001 | WO2001023597A9 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
11/22/2001 | WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
11/22/2001 | WO2000055633A9 Methods of screening for colorectal cancer modulators |
11/22/2001 | US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
11/22/2001 | US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants |
11/22/2001 | US20010044418 Treatment of allergies |
11/22/2001 | US20010044151 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
11/22/2001 | US20010044148 EBV-infected stomach cancer cell line |
11/22/2001 | US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
11/22/2001 | US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
11/22/2001 | US20010044135 Chimeric molecules and novel assay system |
11/22/2001 | US20010044133 Phage-dependent super-production of biologically active protein and peptides |
11/22/2001 | US20010044118 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
11/22/2001 | CA2409703A1 Novel differentiation inducing process of embryonic stem cell to ectodermal cell and its use |
11/22/2001 | CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
11/22/2001 | CA2409361A1 Humanised antibodies to the epidermal growth factor receptor |
11/22/2001 | CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
11/22/2001 | CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/22/2001 | CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus |
11/22/2001 | CA2408745A1 Anti-angiogenic polypeptides |
11/22/2001 | CA2408691A1 Compositions and methods for achieving immune suppression |
11/22/2001 | CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides |
11/22/2001 | CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy |
11/22/2001 | CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
11/22/2001 | CA2408134A1 G-protein coupled receptors |
11/22/2001 | CA2407707A1 In vitro fucosylation recombinant glycopeptides |
11/22/2001 | CA2398979A1 Novel bee venom polypeptides and methods of use thereof |
11/21/2001 | EP1156334A2 Method for screening a substance having promoting activity on hair growth |
11/21/2001 | EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction |
11/21/2001 | EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
11/21/2001 | EP1156110A2 G-protein coupled receptor (HFGAN72Y) |
11/21/2001 | EP1156064A2 Cat-mouse chimeric antibody directed to feline diseases and corresponding heterohydridoma |
11/21/2001 | EP1156061A1 Reagent for the diagnosis of rheumatoid arthritis |
11/21/2001 | EP1155700A2 Lymphocyte chemoattractant factor and uses thereof |
11/21/2001 | EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes |
11/21/2001 | EP1155124A2 In vitro translation system |
11/21/2001 | EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
11/21/2001 | EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
11/21/2001 | EP1155028A1 Pigment protein from coral tissue |
11/21/2001 | EP1154797A2 Multi-mutant diphtheria toxin vaccines |
11/21/2001 | EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
11/21/2001 | EP1154703A1 Method for preparing albumin hydrolysates |
11/21/2001 | EP1154702A1 Method for preparing an albumin isolate from a substance containing albumin |
11/21/2001 | EP1154692A1 A method of controlling fungal pathogens, and agents useful for same |
11/21/2001 | EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
11/21/2001 | EP0842191B1 Cyclosporin derivatives with anti-hiv activity |
11/21/2001 | EP0773962B1 Antibodies which activate an erythropoietin receptor |
11/21/2001 | EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors |
11/21/2001 | EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
11/21/2001 | EP0711305B1 Protegrins |
11/21/2001 | EP0536186B1 Bone and cartilage inductive proteins |
11/21/2001 | CN1323348A Delivery system for porcine somatotropin |
11/21/2001 | CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
11/21/2001 | CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide |
11/21/2001 | CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof |
11/21/2001 | CN1075113C Realignment protein of human digestive enzyme and process for their preparation |
11/21/2001 | CN1075112C Producing process of HEV Protein and method of testing HEV infection |
11/21/2001 | CN1075078C Producing process of stem cell factor |
11/20/2001 | US6320037 IBD-associated microbial nucleic acid molecules |
11/20/2001 | US6320036 GbpA |
11/20/2001 | US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors |
11/20/2001 | US6319713 Methods and compositions for polypeptide engineering |
11/20/2001 | US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders |
11/20/2001 | US6319700 Human choline acetyltransferase |
11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
11/20/2001 | US6319690 Preparation and use of gene banks of human antibodies (“human-antibody libraries”) |
11/20/2001 | US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing |
11/20/2001 | US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) |
11/20/2001 | US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene |
11/20/2001 | US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools |
11/20/2001 | US6319685 Polypeptide for generation of amidated agricultral and medical products |
11/20/2001 | US6319677 Monitoring seed development; evaluate migration of globulins in seed extracts, migration of globulins indicates seed development activity |
11/20/2001 | US6319669 Nucleotide sequences coding luminescent polypeptides; for use as genetic tools in monitoring intracelular positions of preferential polypeptides and preferential gene expression |
11/20/2001 | US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections |
11/20/2001 | US6319503 Fusion protein comprising ubiquitin fused to single epitope-containing segment comprising two or more identical epitopes, wherein segment is not cleaved from protein by exposure to ubiquitin-specific proteases; immunogens |
11/20/2001 | US6319502 Immunogenic polypeptide; treating malaria |
11/20/2001 | US6319500 Detection and treatment of infections with immunoconjugates |
11/20/2001 | US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence |
11/20/2001 | CA2096418C Expression of pace in host cells and methods of use thereof |
11/20/2001 | CA2084521C Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method |
11/20/2001 | CA2077691C Oxidation resistant thrombomodulin analogs |
11/20/2001 | CA2065022C Rubella peptides |
11/20/2001 | CA2053864C Modified forms of reproductive hormones |
11/19/2001 | CA2324167A1 A membrane-bound netrin |
11/18/2001 | CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
11/15/2001 | WO2001086293A2 A method for designing and screening random libraries of compounds |
11/15/2001 | WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses |
11/15/2001 | WO2001085984A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals |
11/15/2001 | WO2001085980A2 Enzymatic assays for screening anti-cancer agents |
11/15/2001 | WO2001085977A2 Chemoenzymatic synthesis of neotame |
11/15/2001 | WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
11/15/2001 | WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
11/15/2001 | WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
11/15/2001 | WO2001085945A1 Method of inhibiting the formation of by-product in the production of genetically modified polypeptide |